NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
Nkarta, Inc.
Nkarta, Inc.
Verismo Therapeutics
Poseida Therapeutics, Inc.
LTZ Therapeutics, Inc.
Chengdu Zenitar Biomedical Technology Co., Ltd
Shanghai Exuma Biotechnology Ltd.
ImmunityBio, Inc.
Juno Therapeutics, a Subsidiary of Celgene
Athenex, Inc.
Morphotek
Cellerant Therapeutics
Enzon Pharmaceuticals, Inc.
Daiichi Sankyo
MedImmune LLC